IJSDR
IJSDR
INTERNATIONAL JOURNAL OF SCIENTIFIC DEVELOPMENT AND RESEARCH
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2455-2631 | Impact factor: 8.15 | ESTD Year: 2016
open access , Peer-reviewed, and Refereed Journals, Impact factor 8.15

Issue: April 2024

Volume 9 | Issue 4

Impact factor: 8.15

Click Here For more Info

Imp Links for Author
Imp Links for Reviewer
Research Area
Subscribe IJSDR
Visitor Counter

Copyright Infringement Claims
Indexing Partner
Published Paper Details
Paper Title: Role Of Remdesivir In Covid-19: A Review Of Pharmacology, Preclinical And Clinical Studies Of Drug.
Authors Name: Dr. Shital Dhawane , Miss. Snehal Dherange , Mr. Shivam Banarase
Unique Id: IJSDR2008013
Published In: Volume 5 Issue 8, August-2020
Abstract: In December 2019 the outbreak of corona virus, occurred in Wuhan City, China. COVID-19, which has affected at least 114 countries and more than 608K people dead. On 11 march 2020 the WHO officially declares it a pandemic. As the world scrambles to find a way to prevent corona virus infections, medical experts are evaluating and working on every available lead. Health workers are currently making efforts to control further disease outbreaks caused by the novel CoV-19.Remdesivir shows the therapeutic approach in numerous clinical trials. Remdesivir is a nucleotide analogue prodrug that rattled the viral replication, originally evaluated in clinical trials to oblique the Ebola outbreak in 2014. There are almost ten clinical trials of remdesivir are investigated against COVID-19. The dose for remdesivir is administered through IV rout which is 200 mg on day 1 followed by daily IV maintenance doses of 100 mg for 5–9 days. In this study we overviewed the discovery of remdesivir, mechanism of action, the current clinical trials and the effectiveness of remdesivir.
Keywords: Corona virus, Remdesivir, (GS-5734), SARS-CoV2.
Cite Article: "Role Of Remdesivir In Covid-19: A Review Of Pharmacology, Preclinical And Clinical Studies Of Drug.", International Journal of Science & Engineering Development Research (www.ijsdr.org), ISSN:2455-2631, Vol.5, Issue 8, page no.87 - 102, August-2020, Available :http://www.ijsdr.org/papers/IJSDR2008013.pdf
Downloads: 000337071
Publication Details: Published Paper ID: IJSDR2008013
Registration ID:192264
Published In: Volume 5 Issue 8, August-2020
DOI (Digital Object Identifier):
Page No: 87 - 102
Publisher: IJSDR | www.ijsdr.org
ISSN Number: 2455-2631

Click Here to Download This Article

Article Preview

Click here for Article Preview







Major Indexing from www.ijsdr.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

Track Paper
Important Links
Conference Proposal
ISSN
DOI (A digital object identifier)


Providing A digital object identifier by DOI
How to GET DOI and Hard Copy Related
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Creative Commons License
This material is Open Knowledge
This material is Open Data
This material is Open Content
Social Media
IJSDR

Indexing Partner